GB9911804D0 - Therapeutic combination - Google Patents

Therapeutic combination

Info

Publication number: GB9911804D0
Authority: GB; United Kingdom
Prior art keywords: therapeutic combination; therapeutic; combination
Prior art date: 1999-05-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9911804.4A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Organon Pharma UK Ltd

Original Assignee

Merck Sharp and Dohme Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-05-20

Filing date

1999-05-20

Publication date

1999-07-21

1999-05-20 Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd

1999-05-20 Priority to GBGB9911804.4A priority Critical patent/GB9911804D0/en

1999-07-21 Publication of GB9911804D0 publication Critical patent/GB9911804D0/en

2000-05-11 Priority to GB0011408A priority patent/GB2352630A/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychology (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Plural Heterocyclic Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB9911804.4A 1999-05-20 1999-05-20 Therapeutic combination Ceased GB9911804D0 (en)

Priority Applications (2)

Application Number	Priority Date	Filing Date	Title
GBGB9911804.4A GB9911804D0 (en)	1999-05-20	1999-05-20	Therapeutic combination
GB0011408A GB2352630A (en)	1999-05-20	2000-05-11	Inverse agonist of GABA-A alpha-5 receptor subtype/amyloid ß aggregation inhibitor combination & treating neurodegenerative conditions eg Alzheimer's disease

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9911804.4A GB9911804D0 (en)	1999-05-20	1999-05-20	Therapeutic combination

Publications (1)

Publication Number	Publication Date
GB9911804D0 true GB9911804D0 (en)	1999-07-21

Family

ID=10853862

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
GBGB9911804.4A Ceased GB9911804D0 (en)	1999-05-20	1999-05-20	Therapeutic combination
GB0011408A Withdrawn GB2352630A (en)	1999-05-20	2000-05-11	Inverse agonist of GABA-A alpha-5 receptor subtype/amyloid ß aggregation inhibitor combination & treating neurodegenerative conditions eg Alzheimer's disease

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
GB0011408A Withdrawn GB2352630A (en)	1999-05-20	2000-05-11	Inverse agonist of GABA-A alpha-5 receptor subtype/amyloid ß aggregation inhibitor combination & treating neurodegenerative conditions eg Alzheimer's disease

Country Status (1)

Country	Link
GB (2)	GB9911804D0 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN1688299A (en) *	2002-01-29	2005-10-26	普罗特米克斯公司	Suppression of cytotoxic protein conformers
US6852730B2 (en)	2002-02-07	2005-02-08	Neurogen Corporation	Substituted fused pyrazolecarboxylic acid arylamides and related compounds
US8510055B2 (en)	2005-08-03	2013-08-13	The Johns Hopkins University	Methods for characterizing and treating cognitive impairment in aging and disease
EP2682481A3 (en) *	2005-08-03	2014-09-17	The Johns-Hopkins University	Methods for characterizing and treating cognitive impairment in aging and disease
WO2012068161A1 (en)	2010-11-15	2012-05-24	Agenebio, Inc.	Pyridazine derivatives, compositions and methods for treating cognitive impairment
CA3123897C (en)	2013-12-20	2024-02-06	Agenebio, Inc.	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
MA42624A (en)	2015-06-19	2021-04-28	Agenebio Inc	BENZODIAZEPINE DERIVATIVES, COMPOSITIONS AND TREATMENT METHODS FOR COGNITIVE DEFICIENCY
BR112019012821A2 (en)	2016-12-19	2019-11-26	Agenebio Inc	benzodiazepine derivatives, compositions and methods for the treatment of cognitive impairment
AU2019288382B2 (en)	2018-06-19	2024-07-25	Agenebio, Inc.	Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9503601D0 (en) *	1995-02-23	1995-04-12	Merck Sharp & Dohme	Method of treatment and method of manufacture of medicament
AU724076B2 (en) *	1996-07-25	2000-09-14	Merck Sharp & Dohme Limited	Substituted triazolo pyridazine derivatives as inverse agonists of the GABAAalpha5 receptor subtype
GB9622370D0 (en) *	1996-10-28	1997-01-08	Merck Sharp & Dohme	Therapeutic agents
GB9701628D0 (en) *	1997-01-27	1997-03-19	Pharmacia & Upjohn Spa	Imino-aza-anthracyclinone derivatives
AU732455C (en) *	1997-05-08	2002-09-05	Merck Sharp & Dohme Limited	Substituted 1,2,4-triazolo{3,4-a}phthalazine derivatives as gaba alpha 5 ligands

1999
- 1999-05-20 GB GBGB9911804.4A patent/GB9911804D0/en not_active Ceased
2000
- 2000-05-11 GB GB0011408A patent/GB2352630A/en not_active Withdrawn

Also Published As

Publication number	Publication date
GB2352630A (en)	2001-02-07
GB0011408D0 (en)	2000-06-28

Publication	Publication Date	Title
HK1200316A1 (en)	2015-08-07	Therapeutic microfoams
GB9911863D0 (en)	1999-07-21	Therapeutic agents
GB9905010D0 (en)	1999-04-28	Therapeutic agents
IL150030A0 (en)	2002-12-01	Therapeutic agents
GB9904786D0 (en)	1999-04-28	Therapeutic agents
GB9929685D0 (en)	2000-02-09	Therapeutic agents
GB9929687D0 (en)	2000-02-09	Therapeutic agents
GB9930570D0 (en)	2000-02-16	Therapy
GB9907243D0 (en)	1999-05-26	Therapy
GB9921351D0 (en)	1999-11-10	Therapeutic agents
GB9911881D0 (en)	1999-07-21	Therapeutic agents
GB9903476D0 (en)	1999-04-07	Therapeutic agents
GB9911802D0 (en)	1999-07-21	Therapeutic combination
GB9929569D0 (en)	2000-02-09	Therapeutic agents
GB9911803D0 (en)	1999-07-21	Therapeutic combination
GB9911804D0 (en)	1999-07-21	Therapeutic combination
GB9914745D0 (en)	1999-08-25	Therapeutic agents
GB9914744D0 (en)	1999-08-25	Therapeutic agents
GB9900222D0 (en)	1999-02-24	Therapeutic compounds
GB9903119D0 (en)	1999-04-07	Therapeutic agents
GB9914742D0 (en)	1999-08-25	Therapeutic agents
GB9902881D0 (en)	1999-03-31	Therapeutic agents
GB9911238D0 (en)	1999-07-14	Therapeutic use
GB9914743D0 (en)	1999-08-25	Therapeutic agents
GB9915616D0 (en)	1999-09-01	Therapeutic agents

Legal Events

Date	Code	Title	Description
2000-08-16	AT	Applications terminated before publication under section 16(1)